Dishman Carbogen Amcis Limited (DCAL.BO)

INR 274.5

(-3.18%)

Total Assets Summary of Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited's latest annual total assets in 2023 was 95.81 Billion INR , up 1.35% from previous year.
Dishman Carbogen Amcis Limited's latest quarterly total assets in 2023 FY was 95.81 Billion INR , up 1.35% from previous quarter.
Dishman Carbogen Amcis Limited reported annual total assets of 94.53 Billion INR in 2022, up 9.45% from previous year.
Dishman Carbogen Amcis Limited reported annual total assets of 86.37 Billion INR in 2021, up 3.24% from previous year.
Dishman Carbogen Amcis Limited reported quarterly total assets of 95.81 Billion INR for 2023 Q4, down 0.0% from previous quarter.
Dishman Carbogen Amcis Limited reported quarterly total assets of 95.01 Billion INR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of Dishman Carbogen Amcis Limited (2023 - 2005)

Historical Annual Total Assets of Dishman Carbogen Amcis Limited (2023 - 2005)

Year	Total Assets	Total Assets Growth
2023	95.81 Billion INR	1.35%
2022	94.53 Billion INR	9.45%
2021	86.37 Billion INR	3.24%
2020	83.66 Billion INR	2.03%
2019	81.99 Billion INR	11.89%
2018	73.28 Billion INR	2.12%
2017	71.76 Billion INR	8.84%
2016	65.93 Billion INR	121.22%
2015	29.8 Billion INR	6.11%
2014	28.08 Billion INR	6.9%
2013	26.27 Billion INR	14.69%
2012	22.91 Billion INR	1.87%
2011	22.48 Billion INR	7.9%
2010	20.84 Billion INR	16.29%
2009	17.92 Billion INR	8.34%
2008	16.54 Billion INR	12.57%
2007	14.69 Billion INR	26.6%
2006	11.6 Billion INR	94.91%
2005	5.95 Billion INR	0.0%

Year	Total Assets	Total Assets Growth
2023 Q1	- INR	-100.0%
2023 Q4	95.81 Billion INR	0.0%
2023 Q2	95.01 Billion INR	0.0%
2023 Q3	- INR	-100.0%
2023 FY	95.81 Billion INR	1.35%
2022 Q3	- INR	-100.0%
2022 FY	94.53 Billion INR	9.45%
2022 Q4	94.53 Billion INR	0.0%
2022 Q1	- INR	-100.0%
2022 Q2	88.26 Billion INR	0.0%
2021 Q3	- INR	-100.0%
2021 FY	86.37 Billion INR	3.24%
2021 Q2	85.35 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2021 Q4	86.37 Billion INR	0.0%
2020 FY	83.66 Billion INR	2.03%
2020 Q2	82.15 Billion INR	0.0%
2020 Q4	83.66 Billion INR	0.0%
2019 FY	81.99 Billion INR	11.89%
2019 Q2	77.74 Billion INR	0.0%
2019 Q4	81.99 Billion INR	0.0%
2018 FY	73.28 Billion INR	2.12%
2018 Q4	73.28 Billion INR	0.0%
2018 Q2	76.31 Billion INR	0.0%
2017 FY	71.76 Billion INR	8.84%
2017 Q2	67.25 Billion INR	0.0%
2017 Q4	71.76 Billion INR	0.0%
2016 FY	65.93 Billion INR	121.22%
2016 Q4	65.93 Billion INR	0.0%
2016 Q2	30.86 Billion INR	0.0%
2015 FY	29.8 Billion INR	6.11%
2015 Q4	29.8 Billion INR	0.0%
2015 Q2	28.41 Billion INR	0.0%
2014 Q2	26.4 Billion INR	0.0%
2014 FY	28.08 Billion INR	6.9%
2014 Q4	28.08 Billion INR	0.0%
2013 Q2	25.42 Billion INR	0.0%
2013 Q4	26.27 Billion INR	0.0%
2013 FY	26.27 Billion INR	14.69%
2012 FY	22.91 Billion INR	1.87%
2012 Q4	22.91 Billion INR	0.0%
2011 Q4	22.48 Billion INR	0.0%
2011 FY	22.48 Billion INR	7.9%
2010 FY	20.84 Billion INR	16.29%
2009 FY	17.92 Billion INR	8.34%
2008 FY	16.54 Billion INR	12.57%
2007 FY	14.69 Billion INR	26.6%
2006 FY	11.6 Billion INR	94.91%
2005 FY	5.95 Billion INR	0.0%

Peer Total Assets Comparison of Dishman Carbogen Amcis Limited

Name	Total Assets	Total Assets Difference
Alfavision Overseas (India) Limited	1.78 Billion INR	-5265.891%
Biocon Limited	560.7 Billion INR	82.912%
Blue Jet Healthcare Limited	10.58 Billion INR	-804.891%
Concord Biotech Limited	17 Billion INR	-463.378%
FERMENTA BIOTECH LIMITED	5.47 Billion INR	-1648.972%
GENOMIC VALLEY BIOTECH LIMITED	43.33 Million INR	-220992.162%
Lyka Labs Limited	1.56 Billion INR	-6013.545%
Panacea Biotec Limited	12.4 Billion INR	-672.271%
SAMSRITA LABS LIMITED	155.51 Million INR	-61511.634%
Servoteach Industries Limited	1591.00 INR	-6022256342.489%
SMS Lifesciences India Limited	3.9 Billion INR	-2353.505%
Supriya Lifescience Limited	9.21 Billion INR	-940.058%
Syngene International Limited	61.51 Billion INR	-55.755%
TAKE Solutions Limited	881.05 Million INR	-10774.99%
Titan Biotech Limited	1.56 Billion INR	-6019.183%
Transgene Biotek Limited	324.4 Million INR	-29435.516%
Vanta Bioscience Limited	853.96 Million INR	-11119.896%